Mode
Text Size
Log in / Sign up
Phase 4 Completed N=42 Triple-blind Treatment

ED90 for Hyperbaric Bupivacaine in Super Obese Parturients

Obesity, Morbid · Spinal Anesthesia · Cesarean Delivery
Source: ClinicalTrials.gov NCT03781388 ↗
Enrolled (actual)
42
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcomePrimary: Number of Participants With Successful Blocks for Induction (Success Induction) — 1; 3; 27; 11 Participants
◆ Published Evidence
Emerging
6citations · ~3 / year
The 90% effective dose of intrathecal hyperbaric bupivacaine for Cesarean delivery under combined spinal-epidural anesthesia in parturients with super obesity: an up-down sequential allocation study.
Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2024 · Open access · Likely link

Summary

The aim of this study is to determine the ED90 of hyperbaric intrathecal bupivacaine for the super obese population undergoing cesarean section under a combined spinal epidural technique.

Linked Publications

  • The 90% effective dose of intrathecal hyperbaric bupivacaine for Cesarean delivery under combined spinal-epidural anesthesia in parturients with super obesity: an up-down sequential allocation study.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2024 · 6 citations · Open access · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Successful Blocks for Induction (Success Induction)
1; 3; 27; 11
PRIMARY
Number of Participants With Successful Blocks for Operation (Success Operation)
0; 2; 21; 11
PRIMARY
ED90 (90% Effective Dose) of Intrathecal Bupivacaine for Cesarean Delivery
11.56

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiology (ASA) class 2 and 3
  • English speaking
  • Gestational age > 36 weeks
  • Scheduled for cesarean delivery under combined spinal epidural anesthesia
  • 18 years or older
  • BMI > 50 kg/m2

Exclusion Criteria

  • History of past or current intravenous drug or chronic opioid abuse
  • Allergy or contraindication to any study medications
  • Intrapartum cesarean delivery under epidural anesthesia
  • Cesarean delivery under general anesthesia
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03781388) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search